Cargando…

Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders

INTRODUCTION: We previously reported lower serum 25-hydroxyvitamin D concentrations in patients with Alzheimer’s disease (AD), Parkinson’s disease (PD) and Multiple system atrophy (MSA) compared to healthy controls (HC), whereas 1,25-di-hydroxyvitamin D levels were solely lower in MSA patients. We i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kakimoto, Asako, Ogura, Hiromu, Suenaga, Midori, Mishima, Takayasu, Fujioka, Shinsuke, Ouma, Shinji, Matsunaga, Yoichi, Tsuboi, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441335/ https://www.ncbi.nlm.nih.gov/pubmed/36072127 http://dx.doi.org/10.1016/j.prdoa.2022.100162

Ejemplares similares

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease
por: Ouma, Shinji, et al.
Publicado: (2018)

Fluctuating pain in Parkinson's disease: Its prevalence and impact on quality of life
por: Kurihara, Kanako, et al.
Publicado: (2021)

Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria
por: Tsuboi, Yoshio, et al.
Publicado: (2021)

Hospital-based study on emergency admission of patients with Parkinson's disease
por: Fujioka, Shinsuke, et al.
Publicado: (2016)

HTLV-1-associated demyelinating neuropathy: A case report and review of the literature
por: Tamaki, Keiko, et al.
Publicado: (2023)

Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease
por: Kakimoto, Asako, et al.
Publicado: (2023)

Evaluation of perception threshold and pain in patients with Parkinson’s disease using PainVision(®)
por: Kurihara, Kanako, et al.
Publicado: (2023)

Off Time Independently Affects Quality of Life in Advanced Parkinson's Disease (APD) Patients but Not in Non-APD Patients: Results from the Self-Reported Japanese Quality-of-Life Survey of Parkinson's Disease (JAQPAD) Study
por: Hayashi, Yuka, et al.
Publicado: (2021)

Evaluation of Motor Complications in Parkinson's Disease: Understanding the Perception Gap between Patients and Physicians
por: Ogura, Hiromu, et al.
Publicado: (2021)

Impact of Parkinson's Disease on Caregiver Quality of Life in Japan
por: Nagaki, Koichi, et al.
Publicado: (2023)

The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson’s Disease Patients According to Rome III Diagnostic Criteria
por: Mishima, Takayasu, et al.
Publicado: (2017)

Personalized Medicine in Parkinson’s Disease: New Options for Advanced Treatments
por: Mishima, Takayasu, et al.
Publicado: (2021)

Polymyalgia Rheumatica Following COVID-19 Vaccination
por: Yokote, Akira, et al.
Publicado: (2022)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Impact of insufficient drug efficacy of antiparkinson agents on patient’s quality of life: a cross-sectional study
por: Tsugawa, Jun, et al.
Publicado: (2015)

Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine
por: Mishima, Takayasu, et al.
Publicado: (2022)

Association between physical activity and health literacy in patients with Parkinson’s disease: an online web survey
por: Nagaki, Koichi, et al.
Publicado: (2023)

Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report
por: Yanamoto, Shozaburo, et al.
Publicado: (2016)

Table tennis for patients with Parkinson’s disease: A single-center, prospective pilot study
por: Inoue, Kenichi, et al.
Publicado: (2020)

Unilateral GPi-DBS Improves Ipsilateral and Axial Motor Symptoms in Parkinson’s Disease as Evidenced by a Brain Perfusion Single Photon Emission Computed Tomography Study
por: Hayashi, Yuka, et al.
Publicado: (2022)

The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
por: Ouma, Shinji, et al.
Publicado: (2017)

Siblings with Cockayne Syndrome B Type III Presenting with Slowly Progressive Cerebellar Ataxia
por: Takahashi, Nobutaka, et al.
Publicado: (2023)

In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine
por: Chen, Yong, et al.
Publicado: (2010)

Dysphagia in Perry Syndrome: Pharyngeal Pressure in Two Cases
por: Umemoto, George, et al.
Publicado: (2017)

Environmental Factors Preceding Aβ40 Monomer to Oligomers and the Detection of Oligomers in Alzheimer's Disease Patient Serum
por: Matsunaga, Yoichi, et al.
Publicado: (2012)

Effect of Coleus forskohlii and its major constituents on cytochrome P450 induction
por: Hebbani Nagarajappa, Shivaprasad, et al.
Publicado: (2015)

Screening of the whole human cytochrome P450 complement (CYPome) with enzyme bag cocktails
por: Sharma, Sangeeta Shrestha, et al.
Publicado: (2020)

A Case of Posterior Interosseous Nerve Palsy Associated With Robotic Low Anterior Resection
por: Ohno, Ryo, et al.
Publicado: (2023)

The Cytochrome P450 Homepage
por: Nelson, David R
Publicado: (2009)

Profiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotyping
por: Van Vlaslaer, Anne, et al.
Publicado: (2013)

Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase
por: Cheng, Shen, et al.
Publicado: (2021)

Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450
por: Campelo, Diana, et al.
Publicado: (2018)

Homology modeling of mosquito cytochrome P450 enzymes involved in pyrethroid metabolism: insights into differences in substrate selectivity
por: Lertkiatmongkol, Panida, et al.
Publicado: (2011)

The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
por: Rwere, Freeborn, et al.
Publicado: (2021)

The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation
por: Miura, Mai, et al.
Publicado: (2015)

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
por: Danek, Przemysław J., et al.
Publicado: (2020)

Fungal cytochrome P450 database
por: Park, Jongsun, et al.
Publicado: (2008)

Cytochrome P450 humanised mice
por: Gonzalez, Frank J
Publicado: (2004)

Intronic polymorphisms of cytochromes P450
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_818q7bfkir1ulrhn0r3ssu35m8